RecruitingNot ApplicableNCT07217236

Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG

Evaluation of an Artificial Intelligence-Enhanced Electrocardiogram Strategy Versus Standard Care to Identify Patients Requiring Cardiac Implantable Electronic Devices: A Randomized Controlled Trial

Sponsor

National Defense Medical Center, Taiwan

Enrollment

11,492 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Conditions

Artificial Intelligence (AI)Cardiac Implantable Electrical Devices Conduction Disorder of the Heart

Summary

The goal of this clinical trial is to learn whether an artificial intelligence-enhanced electrocardiogram (AI-ECG) strategy improves timely intervention of patients requiring cardiac implantable electronic devices (CIEDs), compared with standard clinical care.

Eligibility

Min Age: 65 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying AI-ECG driven ECG monitoring for people with artificial intelligence (ai), cardiac implantable electrical devices, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.